Literature DB >> 36271203

Densifying Co-Precipitated Amorphous Dispersions to Achieve Improved Bulk Powder Properties.

Derek S Frank1, Ashish Punia2, Mairead Fahy3, Chad Dalton4, Jasmine Rowe4, Luke Schenck5.   

Abstract

PURPOSE: Precipitation of amorphous solid dispersions has gained traction in the pharmaceutical industry given its application to pharmaceuticals with varying physicochemical properties. Although preparing co-precipitated amorphous dispersions (cPAD) in high-shear rotor-stator devices allows for controlled shear conditions during precipitation, such aggressive mixing environments can result in materials with low bulk density and poor flowability. This work investigated annealing cPAD after precipitation by washing with heated anti-solvent to improve bulk powder properties required for downstream drug product processing.
METHODS: Co-precipitation dispersions were prepared by precipitation into pH-modified aqueous anti-solvent. Amorphous dispersions were washed with heated anti-solvent and assessed for bulk density, flowability, and dissolution behavior relative to both cPAD produced without a heated wash and spray dried intermediate.
RESULTS: Washing cPAD with a heated anti-solvent resulted in an improvement in flowability and increased bulk density. The mechanism of densification was ascribed to annealing over the wetted Tg of the material, which lead to collapse of the porous co-precipitate structure into densified granules without causing crystallization. In contrast, an alternative approach to increase bulk density by precipitating the ASD using low shear conditions showed evidence of crystallinity. The dissolution rate of the densified cPAD granules was lower than that of the low-bulk density dispersions, although both samples reached concentrations equivalent to that of the spray dried intermediate after 90 min dissolution.
CONCLUSIONS: Hot wash densification was a tenable route to produce co-precipitated amorphous dispersions with improved properties for downstream processing compared to non-densified powders.
© 2022. Merck & Co., Inc., Rahway, NJ, USA and its affiliates.

Entities:  

Keywords:  amorphous dispersion; annealing; co-precipitation; co-processed API; microprecipitated bulk powder

Year:  2022        PMID: 36271203     DOI: 10.1007/s11095-022-03416-6

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.580


  31 in total

Review 1.  Amorphous pharmaceutical solids: preparation, characterization and stabilization.

Authors:  L Yu
Journal:  Adv Drug Deliv Rev       Date:  2001-05-16       Impact factor: 15.470

Review 2.  Challenges and Strategies in Thermal Processing of Amorphous Solid Dispersions: A Review.

Authors:  Justin S LaFountaine; James W McGinity; Robert O Williams
Journal:  AAPS PharmSciTech       Date:  2015-08-26       Impact factor: 3.246

3.  The application of temperature-composition phase diagrams for hot melt extrusion processing of amorphous solid dispersions to prevent residual crystallinity.

Authors:  Dana E Moseson; Lynne S Taylor
Journal:  Int J Pharm       Date:  2018-10-25       Impact factor: 5.875

Review 4.  Downstream processing of polymer-based amorphous solid dispersions to generate tablet formulations.

Authors:  B Démuth; Z K Nagy; A Balogh; T Vigh; G Marosi; G Verreck; I Van Assche; M E Brewster
Journal:  Int J Pharm       Date:  2015-03-28       Impact factor: 5.875

Review 5.  Strategies to address low drug solubility in discovery and development.

Authors:  Hywel D Williams; Natalie L Trevaskis; Susan A Charman; Ravi M Shanker; William N Charman; Colin W Pouton; Christopher J H Porter
Journal:  Pharmacol Rev       Date:  2013-01       Impact factor: 25.468

6.  Spray drying ternary amorphous solid dispersions of ibuprofen - An investigation into critical formulation and processing parameters.

Authors:  Ahmad Ziaee; Ahmad B Albadarin; Luis Padrela; Alexandra Faucher; Emmet O'Reilly; Gavin Walker
Journal:  Eur J Pharm Biopharm       Date:  2017-08-16       Impact factor: 5.571

Review 7.  Amorphous solid dispersions and nanocrystal technologies for poorly water-soluble drug delivery - An update.

Authors:  Scott V Jermain; Chris Brough; Robert O Williams
Journal:  Int J Pharm       Date:  2017-11-08       Impact factor: 5.875

8.  The effects of spray drying, HPMCAS grade, and compression speed on the compaction properties of itraconazole-HPMCAS spray dried dispersions.

Authors:  Moshe Honick; Sharmila Das; Stephen W Hoag; Francis X Muller; Alaadin Alayoubi; Xin Feng; Ahmed Zidan; Muhammad Ashraf; James E Polli
Journal:  Eur J Pharm Sci       Date:  2020-09-16       Impact factor: 4.384

9.  Mechanical Properties and Tableting Behavior of Amorphous Solid Dispersions.

Authors:  Sarsvat Patel; Xiang Kou; Hao Helen Hou; Ye Bill Huang; John C Strong; Geoff G Z Zhang; Changquan Calvin Sun
Journal:  J Pharm Sci       Date:  2016-10-18       Impact factor: 3.534

Review 10.  Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs.

Authors:  Shrawan Baghel; Helen Cathcart; Niall J O'Reilly
Journal:  J Pharm Sci       Date:  2016-01-23       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.